Alpha Biopharma

BioCheck is a leading provider of high-quality in vitro diagnostic products, including instruments, antibodies, and ELISA kits, designed to meet the highest standards of quality and specificity. With the recent acquisition of DRG International and its subsidiaries, BioCheck has expanded its global distribution capabilities, ensuring quick and reliable delivery of their products worldwide. Committed to transforming healthcare, BioCheck leverages technology and data to improve patient outcomes, reduce costs, and promote equitable access to care. Their value-based diagnostics approach empowers healthcare providers to make informed decisions and deliver personalized care, while their focus on well-established diagnostics enables early detection and intervention, ultimately saving lives and improving health outcomes.Generated from the website

The Parker Institute for Cancer Immunotherapy in San Francisco, CA is dedicated to accelerating the development of breakthrough immune therapies to transform all cancers into curable diseases. Through strategic partnerships with academic collaborators, pharma, biotech, and nonprofit organizations, they focus on pioneering research and inventions in cancer immunotherapy. With a mission to develop breakthrough immune therapies, the Parker Institute for Cancer Immunotherapy aims to turn all cancers into curable diseases faster. Led by a team of dedicated staff and renowned thinkers, they work towards their vision of revolutionizing cancer treatment and improving patient outcomes.Generated from the website

Portola Pharmaceuticals is a Bay Area–based pharmaceuticals company with a focus on bioresearch and drug development. Their efforts are directed towards global markets, specifically in the treatment of cardiovascular disease and inflammation. Generated from their available business information